Leslie Tari - 14 Aug 2023 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Shane Ward, Attorney-in-Fact
Issuer symbol
CDTX
Transactions as of
14 Aug 2023
Net transactions value
+$9,700
Form type
4
Filing time
14 Aug 2023, 19:40:18 UTC
Previous filing
29 Mar 2023
Next filing
13 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Purchase $9,700 +10,000 +3.5% $0.9700 294,179 14 Aug 2023 Direct F1
holding CDTX Common Stock 1,484 14 Aug 2023 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) on May 19, 2023.